Showing Results for
- Academic Journals (1,190)
Search Results
- 1,190
Academic Journals
- 1,190
-
From:Indian Journal of Nuclear Medicine (Vol. 28, Issue 3) Peer-ReviewedByline: Ameya. Puranik, Nilendu. Purandare, Archi. Agrawal, Sneha. Shah, Venkatesh. Rangarajan Sinister undesirable pathologies often accompany malignancies. Though the entire emphasis is on cancer management, these...
-
From:Indian Journal of Palliative Care (Vol. 20, Issue 2) Peer-ReviewedByline: Mojgan. Forootan, Morteza. Tabatabaeefar, Nakisa. Maghsoodi, Maryam. Ardeshiri, Mahdi. Fatemi, Hormat. Rahimzadeh Introduction: Evaluation of quality of life is very important in cancer patients....
-
From:Journal of Carcinogenesis (Vol. 13, Issue 1) Peer-ReviewedByline: Puja. Gaur, Min. Kim, Brian. Dunkin The incidence of esophageal cancer remains on the rise worldwide and despite aggressive research in the field of gastrointestinal oncology, the survival remains poor. Much...
-
From:Indian Journal of Cancer (Vol. 48, Issue 3) Peer-ReviewedByline: A. Chowhan, A. Jena, S. Kinnera, R. Patnayak, O. Reddy, K. Reddy Sir, The occurrence of a second malignancy in a patient with a known malignant tumor is not very uncommon. Tumors of the ovary represent...
-
From:MPR Hematology and Oncology Edition (Vol. 4, Issue 4)GASTRIC CANCERS (STOMACH, ESOPHAGEAL, GASTROESOPHAGEAL JUNCTIONS) General treatment note: In response to the shortage of leucovorin over the last few years, the FDA recently approved levoleucovorin (Fusilev) to be used...
-
From:Reactions Weekly (Issue 1326)[*][S] Four patients developed either acute myeloid leukaemia (AML; patients 1, 2 and 4) or Burkitt leukaemia following treatment with nedaplatin and fluorouracil in addition to radiotherapy for oesophageal cancer....
-
From:Cases Journal (Vol. 2) Peer-ReviewedAuthors: Panagiotis Yannopoulos [1]; Konstantinos Manes (corresponding author) [1] Introduction Fibrovascular polyps (FVP) are rare, benign "tumorlike" lesions of the esophagus, that usually remain asymptomatic....
-
From:Cases Journal (Vol. 1, Issue 28) Peer-ReviewedAuthors: Quor Meng Leong (corresponding author) [1]; Juinn Huar Kam [2] Background Primary malignant melanomas of the oesophagus are extremely rare oesophageal neoplasms and an uncommon presentation of the...
-
From:Expert Review of Anticancer Therapy (Vol. 8, Issue 6) Peer-ReviewedAuthor(s): Yixing Jiang 1 , Eric T Kimchi 2 , Alberto J Montero 3 , Kevin F Staveley-O'Carroll 4 , Jaffer A Ajani [[dagger]] 5 Keywords: current treatment approaches; esophageal cancer; gastric cancer;...
-
From:Oncology (Vol. 21, Issue 11) Peer-ReviewedMatthew J. Schuchert, MD Assistant Professor of Surgery James D. Luketich, MD Professor of Surgery Chief, Division of Thoracic and Foregut Surgery Heart, Lung and Esophageal Surgery Institute UPMC...
-
From:Expert Review of Molecular Diagnostics (Vol. 4, Issue 5) Peer-ReviewedScientists in the UK have developed a novel, minimally invasive technique to detect early stage esophageal cancer, which could potentially improve prognosis for many patients. Esophageal cancer develops in cells that...
-
From:Gut (Vol. 53, Issue 4) Peer-ReviewedBackground: The role of androgen receptors (AR) in tumorigenesis, including transcription of fibroblast growth factors (FGFs), is established in prostate cancer but not oesophageal adenocarcinoma, where incidence is...
-
From:Chest (Vol. 107, Issue 6) Peer-ReviewedTreatment of esophageal carcinoma with radiation alone or surgery alone has yielded unsatisfactory cure rates and has not had a major impact on survival. The failure to cure or prolong survival of patients with...
-
From:Chest (Vol. 112, Issue 4) Peer-ReviewedThe prognosis for patients with carcinoma of the esophagus remains poor despite the recent use of aggressive combination therapies and radical surgical resection. Attempts to improve the survival of patients with...
-
From:PLoS ONE (Vol. 9, Issue 3) Peer-ReviewedAuthor(s): Xuguang Rao 1,2, Daofu Huang 1, Xuxia Sui 3, Gefei Liu 3, Xuhong Song 3, Jinglian Xie 1, Dongyang Huang 3,* Introduction Natural antisense transcripts (NATs), also called antisense RNAs, are RNAs that...
-
From:Indian Journal of Medical and Paediatric Oncology (Vol. 39, Issue 1) Peer-ReviewedByline: Amit. Joshi, Vanita. Noronha, Avinash. Pandey, Vijay. Patil, Aseem. Samar, Abhishek. Mahajan, Amit. Janu, Kumar. Prabhash Background: In advanced esophageal cancer, combination chemotherapy regimens provide...
-
From:Journal of Biomedical Science (Vol. 21, Issue 1) Peer-ReviewedAuthor(s): Forn-Chia Lin1,2 , Yu-Cheng Lee1 , Yih-Gang Goan3,4 , Chen-Hsun Tsai1 , Yun-Chin Yao1 , Hui-Chuan Cheng1 , Wu-Wei Lai5 , Yi-Ching Wang6 , Bor-Shyang Sheu1,7 and Pei-Jung Lu1 Background Esophageal cancer...
-
From:PLoS ONE (Vol. 9, Issue 4) Peer-ReviewedBackground: Barrett's esophagus (BE) occurs as consequence of reflux and is a risk factor for esophageal adenocarcinoma. The current "gold-standard" for diagnosing BE is endoscopy which remains prohibitively expensive...
-
From:BioMed Research International (Vol. 2017) Peer-ReviewedThe incidence and histological type of esophageal cancer are highly variable depending on geographic location and race/ethnicity. Here we want to determine if racial difference exists in the molecular features of...
-
From:Chest (Vol. 116, Issue 6) Peer-ReviewedThe definition of a standard therapy for resectable esophageal cancer remains a clinical controversy. In the past decade, a variety of strategies have been developed in an attempt to improve local control and decrease...